Sri Lanka's First Licensed Medical Cannabis Exporter

Pharmaceutical Purity Grown in Ceylon

License No.
RCC4034/24/PL

EU-GMP designed cultivation. Unlimited export license. Where 3,000 years of Ayurvedic heritage meets pharmaceutical-grade precision for global medical markets.

Where Ancient Roots Meet
Pharmaceutical Precision

100% Indoor
Pharmaceutical-Grade
EU-GMP Designed
About Gammaa Extracts

Sri Lanka's First &
World's Most Trusted

We hold one of only seven licenses issued in Sri Lanka. Our facility combines world-leading Cannabis growing technology and know-how with Sri Lanka’s unique equatorial climate to produce pharmaceutical-grade Cannabis for the world’s most demanding medical markets.

Located at the Sri Lankan Board of Investment (BOI) Export Zone
Secured premium site with 24/7 security infrastructure, biometric controls, and full logistics access.
Fully Funded
Confirmed financing from two of Sri Lanka's leading banking institutions and internal investors.
Explore About Us
Products

Our Pharmaceutical Range

In Development
Gammaa Extracts' Product Range is Currently in Development
Gammaa Extracts is developing a portfolio of medical Cannabis products aligned with global standards, regulated-market expectations, quality systems, and long-term commercial readiness.
Ayurvedic Heritage

3,000 Years of
Botanical Wisdom
Now Pharmaceutical

In Ceylon, Cannabis has been used for millennia as a sacred ‘Osu’ (medicine). Gammaa Extracts honors this legacy by preserving indigenous landrace genetics while refining them in ultra-modern cleanroom environments.

Hela Wedakama Certified
Ministry of Health and Ayurveda Approved
Ancient Genealogy Strains
Explore Ceylon Cannabis
~3000
BCE – Ayurvedic Origins
Initial documentation of medical Cannabis in traditional Sri Lankan medical scrolls.
1867
Colonial Regulation
The first formal categorization of botanical extracts in Ceylon by the British administration.
1960
Ayurveda Act – Sri Lanka
Ceylon's Ayurveda Act No. 31 legally governs Ayurvedic medicine and production.
2024
Legalization of medical grade Cannabis for Export
Gammaa obtained their temporary license - RCC4034/24/PL for global pharmaceutical grade cannabis export.
2026
The start of the journey taking Ceylon Cannabis to the world
Official market entry – Ceylon Cannabis X Gammaa Extracts
Consultants

Strategic Partners

Global Reach

From the Island of
Ceylon to the World

Sri Lanka’s strategic equatorial position provides exceptional connectivity to European, Middle Eastern, and Asia-Pacific markets through well-established maritime and air freight routes. Leveraging Sri Lanka’s BOI-affiliated infrastructure, Gammaa Extracts is strategically positioned from inception to serve the global medical Cannabis supply chain.

Become an Investor
Insights

Intelligence that Builds Global Confidence

Finance

Market Opportunity

The $444 Billion Case for Sri Lanka’s First-Mover Advantage

With only seven licenses and no unlimited exporters, the chance to lead the global market lasts months, not years.With only seven licenses and no unlimited exporters, the chance to lead the global market lasts months, not years.With only seven licenses and no unlimited exporters, the chance to lead the global market lasts months, not years.With only seven licenses and no unlimited exporters, the chance to lead the global market lasts months, not years.

Read More

Heritage

Pharmacology

From Ayurvedic Tradition to Pharmacopoeia: Ceylon’s 3,000-Year Story

Sri Lanka’s Ayurveda Department licenses Gammaa Extracts, linking it to the oldest botanical medicine tradition.Sri Lanka’s Ayurveda Department licenses Gammaa Extracts, linking it to the oldest botanical medicine tradition.Sri Lanka’s Ayurveda Department licenses Gammaa Extracts, linking it to the oldest botanical medicine tradition.Sri Lanka’s Ayurveda Department licenses Gammaa Extracts, linking it to the oldest botanical medicine tradition.Sri Lanka’s Ayurveda Department licenses Gammaa Extracts, linking it to the oldest botanical medicine tradition.

Read More

Finance

Market Opportunity

The $444 Billion Case for Sri Lanka’s First-Mover Advantage

With only seven licenses and no unlimited exporters, the chance to lead the global market lasts months, not years.With only seven licenses and no unlimited exporters, the chance to lead the global market lasts months, not years.With only seven licenses and no unlimited exporters, the chance to lead the global market lasts months, not years.With only seven licenses and no unlimited exporters, the chance to lead the global market lasts months, not years.

Read More

Regulation

EU Markets

How EU-GMP Certification is Reshaping Asia’s Cannabis Export Landscape

As European pharmaceutical buyers tighten quality requirements, producers across Asia face a compliance crossroads. As European pharmaceutical buyers tighten quality requirements, producers across Asia face a compliance crossroads. As European pharmaceutical buyers tighten quality requirements, producers across Asia face a compliance crossroads. As European pharmaceutical buyers tighten quality requirements, producers across Asia face a compliance crossroads.

Read More
Begin the Conversation

Ready to Source Pharmaceutical-Grade Cannabis from Ceylon?